Nat-Teriflunomide 14 mg (Teriflunomide TABLET) 14 MG

Teriflunomide 14 mg tablets are used to manage specific autoimmune conditions. This oral medication is designed to help control immune system responses.

Strength

14 MG

Manufacturer / TM Owner

NATCO PHARMA (CANADA) INC

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Teriflunomide 14 mg tablets are primarily used to treat relapsing forms of multiple sclerosis. This medication works by modulating the immune system to reduce inflammation and slow disease progression. It is often prescribed for individuals experiencing frequent relapses. Teriflunomide is also used in other autoimmune conditions where immune system regulation is beneficial.

Side Effects

Common effects of teriflunomide may include headaches, diarrhea, and hair thinning. Some individuals might experience nausea or fatigue. These effects can vary in intensity and duration. It's important to monitor any persistent or severe symptoms and consult a healthcare provider if necessary.

Precautions & Warnings

Teriflunomide should be handled with care, especially during pregnancy, as it can cause harm to an unborn child. Regular blood tests may be recommended to monitor liver function and blood cell counts. Avoid taking teriflunomide if you have severe liver problems or a known hypersensitivity to the active ingredient.

Avoid Interactions

Teriflunomide may interact with certain medications, including those metabolized by the liver. Alcohol consumption should be limited, as it can increase the risk of liver-related side effects. Always inform your healthcare provider about all medications and supplements you are taking to avoid potential interactions.

Frequently Asked Questions

Teriflunomide is primarily used to treat relapsing forms of multiple sclerosis by modulating the immune system.

Teriflunomide tablets are taken orally, typically once daily. Follow the instructions provided by your healthcare provider.

Common side effects include headaches, diarrhea, hair thinning, nausea, and fatigue.

Teriflunomide should be avoided during pregnancy due to potential risks to the unborn child.

The onset of action can vary, but improvements in symptoms may be noticed within a few weeks to months.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.